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Beneficial effects of a high-protein, low-glycemic-load hypocaloric diet in 
overweight and obese women with polycystic ovary syndrome: a randomized 
controlled intervention study 
Abstract 
OBJECTIVE: The recommended composition of a hypocaloric diet for obese women with polycystic ovary 
syndrome (PCOS) is unclear. The aim of this study was to investigate the effects of a high-protein, low-
glycemic-load diet compared with a conventional hypocaloric diet on reproductive hormones, 
inflammatory markers, lipids, glucose, and insulin levels in obese women with PCOS. METHODS: A total of 
60 overweight and obese women with PCOS who did not use insulin-sensitizing agents were recruited and 
randomly assigned to 1 of the 2 hypocaloric diet groups for a single-blind clinical trial. The groups 
included a conventional hypocaloric diet (CHCD) (15% of daily energy from protein) and a modified 
hypocaloric diet (MHCD) with a high-protein, low-glycemic load (30% of daily energy from protein plus 
low-glycemic-load foods selected from a list) that was prescribed via counseling visits weekly during 12 
weeks of study. Anthropometric assessments and biochemical measurements including reproductive 
hormones, inflammatory factors, lipids, glucose, and insulin were performed on fasting blood samples at 
baseline and after 12 weeks of dietary intervention. RESULTS: Weight loss was significant and similar in 
the 2 groups. Mean of testosterone in the MHCD and CHCD groups decreased from 1.78 ± 0.32 to 1.31 ± 
0.26 ng/ml and from 1.51 ± 0.12 to 1.15 ± 0.11 ng/ml, respectively (p < 0.001). Follicle sensitizing 
hormone (FSH), luteinizing hormone (LH), and blood lipids concentrations were not changed except low-
density lipoprotein cholesterol (LDL-C) was reduced by 24.5% ± 12.3% (p < 0.001 for both) after 12 weeks 
of intervention. MHCD resulted in a significant reduction in insulin level, homeostatic model assessment 
for insulin resistance (HOMA), and high-sensitivity C- reactive protein (hsCRP) concentration (p < 0.001). 
CONCLUSIONS: In this study both hypocaloric diets significantly led to reduced body weight and androgen 
levels in these two groups of women with PCOS. The combination of high-protein and low-glycemic-load 
foods in a modified diet caused a significant increase in insulin sensitivity and a decrease in hsCRP level 
when compared with a conventional diet 
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Running Title: Effects of high protein low GL diet on PCOS women 
Beneficial effects of a High Protein Low Glycemic Load Hypocaloric Diet in 
overweight and obese women with polycystic ovary syndrome:  
A randomized controlled intervention study 
 
Abstract 
Objective: The recommended composition of a hypocaloric diet for obese women with 
polycystic ovary syndrome (PCOS  ) is unclear. The aim of this study was to investigate the 
effects of a high protein- low glycaemic load diet compared to a conventional hypocaloric diet 
on reproductive hormones, inflammatory markers, lipids, glucose and insulin levels in obese 
women with PCOS.  
Methods: Sixty overweight and obese women with PCOS who did not use insulin sensitizing 
agents were recruited and randomly assigned in one of the two hypocaloric diet groups for a 
single, blinded, clinical trial. The groups included; conventional hypocaloric diet (CHCD) (15% 
of daily energy from protein) and modified hypocaloric diet (MHCD) with high protein-low 
glycaemic load (30% of daily energy from protein plus low glycaemic load foods selected from a 
list) which was prescribed via counseling visits weekly during 12 weeks of study. 
Anthropometric assessments and biochemical measurements including reproductive hormones, 
inflammatory factors, lipids, glucose and insulin were performed on fasting blood samples at 
baseline and after12 weeks of dietary intervention. 
Results: Weight loss was significant and similar in two groups. Mean of testosterone in MHCD 
and CHCD group decreased from 1.78±0.32 to 1.31±0.26 ng/ml and from 1.51±0.12 to 
1.15±0.11 ng/ml, respectively (p<0.001). Follicle sensitizing hormone (FSH), Luteinizing 
hormone (LH), blood lipids concentrations were not changed except -Low density lipoprotein 
cholesterol (LDL-C) was reduced by 24.5%±12.3 (p<0.001 for both) after 12 weeks of 
intervention. MHCD resulted in a significant reduction in insulin level, homeostatic model 
assessment for Insulin resistance (HOMA) and high sensitivity C- reactive protein (hsCRP) 
concentration (p<0.001). 
Conclusions: In this study both hypocaloric diets significantly lead to reduced body weight and 
androgen levels in these two groups of women with PCOS. The combination of high protein and 
low glycemic load foods in modified diet caused a significant increase in insulin sensitivity and a 
decrease in hsCRP level when compared to the conventional diet. 
 
 
Keywords: PCOS, hypocaloric diet, hormones, inflammatory factors, blood lipids, glycaemic 
load, dietary protein  
Introduction: 
Polycystic ovary syndrome (PCOS) was first described more than 70 years ago [1]. It is a 
hormonal imbalance which is generally thought to affect approximately 1 out of 16 women [2]. 
The majority of these women are obese [2]. Obesity can exacerbate the metabolic and 
reproductive abnormalities that are associated with the disorder, mostly by increasing insulin 
resistance and hyperinsulinemia; so weight loss accompanied by an increase in insulin sensitivity 
was highly recommended for this population group [3]. The ideal hypocaloric diet should 
decrease body mass, improve cardiovascular risk factors, and decrease fat tissue while sparing 
lean tissue.   
Low carbohydrate diets were traditionally thought to aid weight loss and improve metabolic and 
reproductive dysfunction [4]. An increasing interest in a high protein/low carbohydrate diet has 
been observed [5]. Stamets et al. compared the short- term effect of a high protein diet (30% 
protein and 40% carbohydrate) or a high carbohydrate diet (15% protein and 55% carbohydrate) 
on weight loss in obese PCOS [6]. Both groups lost approximately 3.6% (high protein group) 
and 4.2% (high carbohydrate group) of body weight, but there were no significant differences 
between the diets [6]. Douglas et al., used eucaloric diets either with mono-unsaturated fatty 
acids (17% of energy) or low carbohydrate (43% of energy) relative to standard diet (56% 
carbohydrate, 31% fat and 16% protein) over 16 days, which resulted in lower fasting insulin and 
acute insulin response to glucose in low carbohydrate diet compared to the standard and mono-
unsaturated fatty acids diets, respectively [7]. Moran et al., studied high protein (30% of total 
calories) versus low protein (15% of total calories) plus exercise for 12 weeks followed by a 4 
week weight maintenance in obese subjects with PCOS. Both groups lost approximately 7.7 kg 
of weight and there was no effect of diet composition [8]. 
Although high protein diet did not make any significant independent difference in comparison to 
other weight loss diets, it seems that protein intake induces satiety and enhances the feeling of 
well- being and also self –esteem for obese PCOS who have tried to lose weight [9]. The concept 
of reducing glycaemic index (GI) and glycaemic load (GL) in the treatment of obese PCOS has 
received considerable interest. GI refers a system for classifying the glycaemic response of 
carbohydrate and measures the relative area under the postprandial glucose curve of 50 g of 
digestible carbohydrates compared with 50 g of a standard food, either glucose or white bread. 
The GL which developed later is calculated by multiplying the GI by the amount of 
carbohydrates in each food [10].  
In 2008 Herriot et al performed a retrospective audit on a group of women with PCOS who had 
been advised to follow a low calorie- low GL diet over a 2 year period. They found that this type 
of diet with 40-45% of daily energy intake from carbohydrate, 30% from protein and about 10% 
from saturated fat together with insulin sensitizing medications caused weight loss and better 
weight maintenance in overweight and obese patients with PCOS [11]. However the impacts of 
the prescribed diets like many similar studies were limited to subjects' self reporting and there 
was a lack of thorough investigation about the final biochemical and anthropometric results. 
Thus the aim of this controlled intervention study was to investigate and compare the effects of 
two kinds of diets including Conventional Hypocaloric Diet (CHCD) and Modified Hypocaloric 
Diet (MHCD) with low GL and high protein content on reproductive hormones, lipid profile, 
inflammatory factors, glucose and insulin levels in overweight and obese women with PCOS 
who had not started taking any medications or changed their exercise habits since the diagnosis 
of their disease. 
Materials and methods: 
A total of 60 women were recruited through newspaper advertisement, brochures and referral of 
gynecologist in an out- patient nutrition clinic visits in Taleghani infertility research center of 
Tehran, Iran.  
Subjects were included if they were aged between 20 and 40 years, had a body mass index (BMI) 
greater than 25 and less than 38 kg/ m2, and no history of using insulin sensitizing agent such as 
metformin or oral contraceptives. Inclusion criteria were diagnosis of PCOS by menstrual 
irregularity (cycle length <21 days or >35 days), hirsutism and biochemical hyperandrogenism. 
Volunteers were excluded if they were smokers, exercised heavily, and/or had any history of 
cardiovascular, renal, gastrointestinal disorders, liver or metabolic diseases. Women diagnosed 
with hyperprolactinemia, thyroid abnormalities, and/or non classic adrenal hyperplasia were also 
excluded from this study. 
The study protocol was approved by the ethics committee of the Institute of Nutrition Sciences 
and Food Technology of Iran and all participants accepted the conditions of the study and gave 
their informed written consent. 
Study design 
It was calculated that 23 subjects per group would provide 80% power to detect a difference of 
7.7 nmol/L in the sex hormone binding globulin (SHBG) levels in serum. Therefore 30 subjects 
were recruited for each group to cover the assumed withdrawal. Subjects were stratified to 
ensure equality of distribution in two groups for known confounding factors like age and BMI, 
and then randomized by an independent observer. Investigator was not blinded as to the kind of 
dietary intervention, but subjects were. 
Dietary intervention for two groups; were the Conventional Hypocaloric Diet (CHCD) and the 
Modified Hypocaloric Diet (MHCD) each for 12 weeks. A dietitian initially instructed the 
subjects on quantification and recording of their daily food intakes. They were followed weekly 
and asked to prepare dietary records for 3 days every month during the intervention (weeks 0, 4, 
8 and 12) to enhance compliance and to enable the dietitian monitoring the prescribed diet. 
Subjects were requested not to change their regular physical activities during the study period. In 
order to check that they were asked to record all their daily physical activity and resting hours at 
the beginning and during the intervention. 
Description of the diets 
For both groups energy content of hypocaloric diet was calculated on the basis of subject’s BMI 
of 21-22 kg/m2 and a deficit of 500 to 1000 kcal (2090-4180 kJ) per day. CHCD consisted of 
55% of energy from carbohydrate, 15% of energy from protein and 30% energy from fat. MHCD 
included 40% of energy from low and medium glycemic load carbohydrates, 30% of energy 
from protein and 30% of energy from fat, with limitation of high glycemic foods. The MHCD 
group refrained from consuming high glycemic load foods (GL≥20). These foods in addition to 
the GL of the other foods were provided to them in a list [12].  In order to assist the subjects in 
meal planning some menu including poultry, fish, legumes, egg white, fruits and non starchy 
vegetables which were similar to their regular dietary habits were suggested by the researcher. In 
these meals the contents of macronutrients were close to the goals of the intervention. 
Furthermore the subjects were instructed about exchanging food items and to insure about their 
diet compliance they were followed by weekly counseling visits.  
Both groups of patients were precisely instructed about the foods that were or were not permitted 
to consume. Eating habits of them were assessed using a food frequency questionnaire [13].   
Anthropometric assessments 
All the anthropometric measurements were assessed in the fasting state. Body composition 
including total body fat and lean body mass were measured at the beginning and the end of the 
intervention using bioelectrical impedance (BioStat Co.,1500, UK). Skinfold thickness was 
measured at suprailiac area using skinfold caliper (Vogel, Germany) in order to determine 
abdominal fatness. Waist circumference was measured at area demarcated by umbilicus and at 
the widest place over the buttocks for hip circumference, by a non- stretchable tape. Subjects 
wore light clothes without shoes when they were weighed (Seca weighing scale, Model 709, 
Seca GmbH & co. kg. Germany)  and their height were measured without shoes. 
Biochemical measurements 
After an overnight fast, 10 ml blood samples were taken. The test was performed either at 
random in the amenorrheic women or 2 to 5 days after menstruation. Follicle stimulating 
hormone (FSH), luteinizing hormone (LH), sex hormone binding globulin (SHBG)  were 
measured by IEMA (Immuno Enzymmometric Assay) method and, estradiol, total testosterone, 
dehydroepiandrosterone sulfate (DHEAS) and androstenedione were determined by Enzyme 
Immuno Assay (EIA ) using a commercially available kit in serum (Diagnostics Biochem 
Canada Inc., Ontario, Canada)[14]. The coefficients of variance (CVs) for these assays were as 
follows: 2.1% for FSH, 4.1% for LH, 3.1% for SHBG, 6.2% for DHEAS, 5% for total 
testosterone, and 5.2% for androstenedione. Fasting insulin and adiponectin were measured using 
ELISA( Enzyme‐Linked Immunosorbent Assay) (Mercodia, Uppsala, Sweden) and CVs were 
7% and 5.1% respectively. Serum glucose, triglyceride, total cholesterol and high density 
lipoprotein cholesterol (HDL-C) were measured by a colorimetric enzymatic assay and the CV 
was lower than 2.5%. Friedewald equation used for low density lipoprotein cholesterol (LDL-C) 
estimation [15]. Interleukin‐6 (IL-6), Tumor Necrosis Factor‐Alpha (TNFα) were measured 
using ELISA (Diaclone, Besancon, France) and their CVs were 5.8% and 7.9% respectively, 
high sensitivity C‐ reactive protein (hsCRP) was measured by ELISA (DBC, Ontario, Canada) 
with CV 9.8%.  HOMA (Homeostatic Model Assessment for Insulin Resistance) was used as a 
surrogate measure of insulin sensitivity and was calculated as [fasting serum insulin (mU/L) × 
fasting serum glucose (mmol/L)/ 22.5] [16]. Free androgen index (FAI) was calculated using the 
formula FAI=T/SHBG × 100 [17]. 
Statistical analyses 
Data were analysed using the statistics package for social sciences 15 (SPSS, Chicago, IL, USA). 
Baseline parametric and non- parametric characteristics of subjects in two groups and also the 
differences between two groups (week 12 minus baseline) were compared by t-test and Mann-
Whitney test. Paired- t- test were performed to evaluate the possible differences between baseline 
and week 12 for each group, separately. P value of <0.05 was considered as significant. 
 The results were analysed in two ways. Firstly a paired t-test was used to compare baseline and 
week 12 data. Secondly, the data of week 12 minus baseline were compared between the 2 
groups.  
Results 
In total 49 out of 60 subjects completed the study, 26 in CHCD and 23 in MHCD. Three had 
difficulty with blood sample draws, 2 could not tolerate any diet, 1 changed her mind and wanted 
to begin IVF processing (In Vitro Fertilization), 2 had family reasons, 1 moved out of the city 
without any forwarding address, and 2 did not provide any reason. 
No significant differences existed in subjects’ characteristics at baseline for two treatment 
groups, except for hip circumference (table 1). Both the MHCD and CHCD diets resulted in 
significant weight loss (p<0.05). None of the subjects had weight gain during the study. The 
range in weight loss was -2 to -10 kg for MHCD and -1 to -9 kg weight loss for the CHCD 
group. It was estimated 4.1%±0.58% and 3.3%±0.62% weight loss for MHCD and CHCD, 
respectively in regards to initial weight, without any significant differences. Subjects in both 
groups did not change their physical activity during the study. Although there was not any 
significant changes in total body fat and lean body mass based on BIA after 12 weeks of 
manipulation of weight reduction diet, but in both groups fat mass was reduced at the end of the 
intervention (Fig.1).  
The reduction of waist circumference in MHCD was significantly more than CHCD (p<0.05). 
Dietary intakes at baseline and after intervention are shown in table 2. There were no significant 
differences in dietary intakes of two groups (zero time). During intervention, daily energy 
intakes decreased with no significant difference between the two. As expected, protein as 
percentage of energy intake was higher and carbohydrate was lower in MHCD, and these 
differed significantly in comparison to CHCD. Contribution of fat in total energy intake 
decreased in both groups. Carbohydrate and total fat intakes were decreased for MHCD and 
replaced by protein. Fiber intake increased by approximately 20% in MHCD group (p<0.05) but 
no difference was observed in fiber intake in the CHCD group. There was not any significant 
difference between the changes of fiber intake in two groups at week 12 (0.3±1.4 g for CHCD 
vs. 2.8±1.4 g for MHCD). 
 There was no effect of energy reduction or diet composition on FSH, LH and blood lipids except 
for LDL-cholesterol which decreased significantly in both groups (table 3). Reduction of LDL-
cholesterol levels were 23.7% ± 13.8% for CHCD and 25.5% ± 10.5% for MHCD without any 
significant differences between the two groups. Mean±SE of fasting glucose for CHCD vs. 
MHCD, respectively at baseline 96.0±1.5 vs. 97.4±1.4 mg/dl (p=0.49) and week 12 was 
98.3±1.7 vs. 98.5±2.5 mg/dl (p=0.95). 
SHBG increased and testosterone, DHEAS decreased in both groups (Table3). There were no 
significant differences between two groups in regard to the changes of reproductive hormones 
(Table 3).  
In addition there were substantial decreases in fasting insulin level and HOMA after 12 weeks 
for both kinds of interventional diets; 25.3% and 23.2 % for MHCD (p<0.001) vs. 5.9% and 
4.2% for CHCD (p<0.001).  However this only remained significant after adjusting for BMI 
changes in MHCD and found to be related directly to the type of diet. TNFα decreased and 
adiponectin increased significantly in both groups (table 4), IL-6 did not change and hsCRP 
decreased in MHCD, which was significant after adjusting for baseline hsCRP. 
Discussion: 
This study demonstrates that both kinds of hypocaloric diets with no medications and instructed 
physical exercise resulted in a significant weight loss, lowering of LDL-cholesterol, reduction of 
androgens and an increase in SHBG, but consumption of the MHCD a hypocaloric diet with low 
GL carbohydrates and high protein content induced concomitant reductions of insulin and 
HOMA and therefore would be viewed as more favorable than the CHCD. 
The attrition rate in this study was about 20% which was much lower than this rate in a recent 
clinical study investigating the effects of low GI diet on women with PCOS [18]. Perhaps 
prescribing the diets according to the patients' regular dietary habits and without any medications 
might be a factor in this higher adherence of patients to their diets in this study.  This is shown in 
these subjects who achieved the macronutrient goals which were set for them through their diets. 
Effects of hypocaloric diets on weight loss 
Even though the benefit of weight loss for women with PCOS is clear but the ideal diet 
composition for their management is not known. There is a paucity in the study of reduced GL 
diets for obese PCOS women. In a retrospective study of normal and obese PCOS by Herriot et 
al., weight and fasting glucose were significantly reduced without changes in insulin 
concentrations for 13 patients by a low GL load diet low GL foods, reduced carbohydrate of 
approximately 40-45% energy, 30% protein, reduced saturated fat of approximately 10% and no 
snacking. The audit indicated that a low GL diet may contribute to an improvement in symptom 
relief in patients with PCOS such as carbohydrate craving and hypoglycemia [11].   
In this study weight loss was similar in the two groups and MHCD did not have any superior 
effect on weight loss compared to CHCD. But MHCD results in a higher decrease of waist and 
hip circumferences that might be due to the lower GL of carbohydrates or higher protein intakes; 
although at baseline the hip circumferences in MHCD had a significant difference with CHCD 
and could explain significant differences at week 12 between MHCD and CHCD.  In the other 
studies the weight reduction was not different for high protein (30%) and low protein (15%) diets 
[8,9]. In the study performed by Moran et al [8] weight loss on high protein and low protein diets 
for the same duration were much higher than this current study. It can be assumed that regular 
class and exercise in their study were the key contributing factors for similar and higher degrees 
of weight loss in both groups.   
Few studies have addressed the effects of varying diet composition on the obese PCOS 
population; hypocaloric diet supplemented with protein reduced fat mass and body weight more 
than diet supplemented with simple sugars [19]. It seems that the subjects receiving higher 
protein may have more successful weight loss because of satiating effect of diet [9, 20], but there 
were no significant differences in hormonal changes attributed to the composition of diet [6]. 
Effects of hypocaloric diets on reproductive hormones and insulin levels 
The improvement of the abnormal reproductive hormones in this current  study were consistent 
with some studies which had observed the effect of weight loss in improving abnormal 
reproductive and metabolic variables in women with PCOS [6, 8, 18 and 21]. It is currently 
unclear why reproductive function is restored with energy restriction or weight loss, how long it 
would take for the hormonal changes to translate into improvements in reproductive functions, 
and what the key triggering hormonal factors are [21]. 
In this study it is hypothesized that a hypocaloric diet with increased protein content and reduced 
GL would decrease insulin concentration and this in turn, results in lowering androgen 
concentrations. The levels of total testosterone and DHEAS decreased similarly in both groups 
after weight loss. In spite of significant decreases of insulin and HOMA in the MHCD group, 
there was no effect of reduced insulin on androgen levels. It seems that the changes in insulin 
concentration in this study were not enough to result in the reduction of androgens. Perhaps this 
was related to insulin resistance, or lower insulin sensitivity in some of the studied subjects, but 
these were not measured directly.  
Similar to the current study, Moran et al. found no significant effect of diet composition on 
testosterone or SHBG levels and showed that endocrine improvements caused maximal changes 
in insulin sensitivity, suggesting a relationship between the two [8]. Decreasing in the level of 
fasting insulin, increasing in SHBG level, and decreasing in testosterone were related to energy 
restriction diets. It is possible that the family of Insulin like Growth Factors (IGFs) and their 
binding proteins may be involved [22], particularly IGF- binding protein-I increases during short 
term energy restriction mediated by decreased insulin levels. Increased IGF- binding protein-I 
decreases free IGF-I, which down regulates androgen synthesis through the cytochrome P450c17 
system [23].  
Free testosterone concentrations are reported to decline significantly following weight loss and 
decrease of insulin concentration [24]. Previously Pasquali et al. showed that moderate weight 
loss resulted in a reduction in insulin levels, but did not alter androgen and DHEAS levels [25].   
There were no effects of weight loss or type of diet seen on LH and FSH. There were no changes 
of these hormones seen in other studies [8, 26]. Guzick et al. observed no effect of weight loss in 
obese hyperandrogenic women and suggested that weight loss had no hypothalamic effect for 
secretion of LH. It is believed that LH concentration is not related to insulin concentration [27]. 
Moreover this current study showed a significant effect of MHCD on insulin concentration and 
HOMA when compared with CHCD.  This suggests that the lower GL in the MHCD group in 
combination with higher protein, improved insulin resistance, as low GL has been shown to 
improve insulin resistance [28, 29].  In contrast, the Moran et al. study showed improvements in 
insulin concentration and HOMA in both energy restricted diets (high carbohydrate/low protein 
and high protein/low carbohydrate) [8]; however, in their study, both groups increased their 
exercise levels and it has been shown that exercise improves insulin resistance in PCOS women 
[30]. These two studies taken together one could speculate that to improve insulin levels and 
HOMA in women with PCOS, the women either go on an energy restricted diet (irrespective of 
composition) so long as they also increase their exercise [8] or the women go on a MHCD diet 
without exercise as shown in this study. A limitation of the Moran et al study was the lack of an 
exercise only arm [8], which would have definitively shown that exercise was responsible for the 
improvements in insulin levels and HOMA.  
Effects on cardiovascular risk factors: 
It has been proposed that excess fat accumulation alters the pattern of adipokines secretion 
causing a low- grade inflammatory state that induces insulin resistance and endothelial 
dysfunction leading to diabetes and cardiovascular disease [31] and conversely fat mass loss or 
weight reduction induce decreasing in cardiovascular risk factors. Some studies showed the 
relation between change of insulin resistance and decreasing in these risk factors [32, 33] but it 
has been assumed that the levels of blood lipids and inflammatory factor at baseline are 
important for observing a significant reduction.  
Noakes et al. reported decrease of serum triacylglycerol after weight loss in obese women with 
high baseline triglycerides [34]. Moran et al also showed reductions in plasma triacylglycerol 
after weight loss (due to energy restricted diets and increased exercise) on women with PCOS 
[8]. In the current study there were no significant differences in plasma triacylglycerol but this 
could be explained by the baseline plasma triacylglycerol levels being approximately 20% lower 
than the baseline plasma triacylglycerols in the study by Moran et al [8].  However, in the current 
study LDL-C decreased in both groups, and this could be due to its higher levels at the beginning 
of the study. Previously dietary GL and carbohydrate has been associated with a number of 
cardiovascular risk factors, reduced HDL-C and elevated triacylglycerol concentrations and also 
hsCRP level [35, 36]. 
There are limited trials for inflammatory factors in obese PCOS women after weight loss by 
hypocaloric diet. CRP was reduced significantly after consumption of an energy restricted diet 
for 8 weeks [21]. But in comparison between women with and without PCOS, there were a 
significant interaction between PCOS status and CRP such that CRP did not decrease with about 
4% weight loss in PCOS women and TNFα increased after weight loss which was surprising 
because usually inflammatory factors decrease after weight loss. Esposito et al. reported 
reduction of inflammatory factors by using a hypocaloric Mediterranean style diet and regular 
physical activity in obese women [37]. In the current study TNFα decreased for both groups and 
IL-6 did not change and hsCRP decreased only in MHCD. In addition decrease in waist 
circumference was higher in MHCD than in CHCD, so reduction of CRP maybe related to this 
variable. Linear regression analysis revealed hsCRP baseline and waist difference parameter and 
individual variability has been suggested to have an important influence on the results [38]. The 
decrease in hsCRP concentration after weight reduction does not appear to be mediated by 
decrease in circulating IL-6 or adiponectin concentrations [39]. Adiponectin increased in both 
group after weight loss which had observed in the other studies [37] but it seems that the change 
in adiponectin level after weight loss did not happen regularly in obese PCOS women [38, 40]. It 
has been suggested to study the ratio of high molecular weight adiponectin to low molecular 
weight adiponectin because of the varying appearance of the two adiponectin oligomers on fat 
and glucose metabolism [41].  
In conclusion the current study demonstrated that two kinds of low calorie diets in women with 
PCOS who had not started taking any medications and without any prescribed exercise have 
significant effects on testosterone, androstenedione, dehydroepiandrosterone, SHBG, FAI, LDL-
C, adiponectin, TNFα and to our knowledge, this is the first interventional study to suggest that 
high protein plus low GL hypocaloric diet without exercise has additional effects on lowering 
insulin level and HOMA.  
However the limitation of this study was that it was a self- reported study in which the 
researchers relied on the study participants for following their prescribed diets, and hence 
controlled-feeding programs for future studies is recommended. Recommendations for future 
studies include considering abdominal fat in addition to BMI as an inclusion criterion, since this 
way the subjects would be metabolically much more similar.  It is also recommended to follow 
up patients for another 6 months to see the weight maintenance and the consequences of weight 
reduction on the reproduction of these groups of women. 
Conclusion 
Both hypocaloric diets without using any medications and instructed exercise were shown to 
significantly reduce body weight and androgens levels in two groups of women with PCOS. In 
addition a high protein-low GL diet caused a significant increase in insulin sensitivity and a 
decrease in hsCRP level when compared to conventional diet. However a study to differentiate 
the effects of protein content and glycemic load in a hypocaloric diet for women with PCOS is 
needed. 
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Values are means±SD. 
CHCD= Conventional Hypocaloric Diet, MHCD=Modified Hypocaloric Diet. There 







Age (years) 28.5±5.2 30.5±6.4 
Weight (kg) 78.9±12.4 83.0±11.7 
BMI (kg/m2) 31.1±4.6 31.9±4.0 
Waist circumference (cm) 102.3±9.9 108.2±8.1 
Hip circumference (cm) 112.1±11.3 120.2±17.1* 
Suprailiac skinfold (mm) 40.0±9.4 44.1±15.7 
Total fat mass (%) 39.9±7.1 40.4±7.5 
Total lean body mass (%) 59.9±7.2 58.8±7.4 
Table 2- Calculated dietary composition of MHCD and CHCD from 4 × 3- days food record in comparison to baseline dietary intakes 
 
Values are means±SE. 
CHCD= Conventional Hypocaloric Diet, MHCD=Modified Hypocaloric Diet; % E, percentage of total daily energy intake.  
Pvalue for changes; Recalls- baseline. 
MHCD (n=23)  CHCD (n=26) 
 pvalueRecalls Baseline Prescribed 
diet 
 pvalue Recalls Baseline Prescribed 
diet 
0.000
6590±280 9472±473 5021-7113  
0.000 
6832±414 9117±515 5021-7113 Energy(kJ/d) 
1575±67 2264±113 1200-1700  1633±99 2179±123 1200-1700             (Kcal/d) 
0.00041.4±2.7 54.7±1.5 40  0.125 55.2± 4.9 57.1±1.7 55 Carbohydrate(% E) 
0.01629.1±2.4 33.7±1.6 30  0.362 30.2±4.6 31.7±2.0 30 Fat (% E) 
0.00029.5±2.5 11.6±2.5 30  0.000 14.6±2.3 11.2±0.5 15 Protein (% E) 
Table 3- Serum concentrations of lipids and reproductive hormones at baseline and after 
intervention 
Data are mean±SE. CHCD= conventional hypocaloric diet; MHCD= modified hypocaloric diet; 
T= testosterone; A4= androstenedione; DHEAS= dehydroepiandrosterone; SHBG= sex hormone 
binding globulin; FSH= follicle stimulating hormone; LH= luteinizing hormone; FAI= free 
androgen index; HDL-C= High density lipoprotein cholesterol; LDL-C= low density lipoprotein 
cholesterol  
 p<0.001, †p<0.01, ‡p<0.05٭
 
 CHCD (n=26)   MHCD (n=23)  
 Baseline week12 change Baseline week12 change 
T (ng/ml) 1.5±0.2 1.1±0.10.2±0.5- †0.2±1.3 0.3±1.8 0.04±0.4- ٭ 
A4 (ng/dl) 1.9±0.1 1.8±0.2 -0.1±0.1 1.9±0.1 1.8±0.1 -0.1±0.1 
DHEAS (ng/ml) 330.1±30.6 298.1±28.9† -32.0±8.9 314.9±31.9 272.8±28.9† -42.1±16.1 
SHBG (nmol/L) 26.9±3.8 37.6±4.6‡ 10.6±4.1 22.7±4.0 31.4±4.4† 8.8±2.8 
FSH (IU/L) 5.2±0.6 4.5±0.5 -0.7±0.5 5.6±0.8 4.9±0.6 -0.7±0.9 
LH (IU/L) 2.9±0.4 2.3±0.4 -0.6±0.4 2.2±0.2 2.6±0.5 0.4±0.6 
FAI 6.6±0.7 4.2±0.50.7±1.9- †0.8±5.1 0.9±7.0 0.5±2.4- ٭ 
Triglyceride (mg/dl) 132.9±7.8 124.4±7.5 -8.6±5.4 128.7±6.5 122.4±5.7 -6.3±6.1 
  Cholesterol (mg/dl) 197.1±5.3 191.6±4.8 -5.5±3.2 199.9±5.8 191.5±5.5 -8.4±4.1 
  HDL-C (mg/dl) 62.4±1.6 61.3±1.2 -1.1±0.8 59.6±1.8 59.2±1.6 -0.4±0.7 
LDL-C (mg/dl) 158.5±6.9 120.0±6.64.3±41.3- ٭4.3±116.7 5.5±158.1 4.9±38.5- ٭ 
Table 4- Serum concentrations of insulin and inflammatory factors at baseline and after 
intervention 
Data are mean±SE. CHCD= conventional hypocaloric diet; MHCD= modified hypocaloric diet;  
  p<0.001, † p<0.05 ٭
The difference between baseline and week 12 are shown on week 12 in each group. 











 CHCD (n=26) MHCD (n=23)  
 Baseline week12 Change Baseline week12 change 
Insulin (mU/ml) 12.2±6.0 11.2±5.3 -1.0±0.7 12.1±3.3 8.4±3.70.7±3.6- ٭† 
HOMA-IR 2.9±1.6 2.7±1.5 -0.3±0.2 2.9±1.4 2.0±0.90.2±0.8- ٭† 
TNFα (pg/ml) 6.3±0.9 3.8±0.8† -2.5±1.1 5.4±0.9 3.3±0.6† -2.1±0.8 
IL-6 (pg/ml) 1.1±0.06 1.0±0.06 -0.1±0.07 1.3±0.1 1.3±0.3 0±0.2 
hsCRP (mg/L) 2.7±0.6 2.6±0.6 -0.1±0.2 3.6±0.8 2.7±0.6† -0.9±0.4 
















Legend of figure1 
Fig.1- Anthropometric changes (%) during 12 weeks use of hypocaloric CHCD and MHCD 
diet. 
 
CHCD= conventional hypocaloric diet; MHCD= modified hypocaloric diet; WC= waist 
circumference, HC=hip circumference, SST= suprailiac skinfold thickness, TBFM= total 
body fat mass. 
All the anthropometric changes were significant for both groups; CHCD and MHCD 
(p<0.05), except for TBFM. 
*p<0.05 in comparison to CHCD. 
 
 
 
 
 
 
 
